CDK2 and hepatocellular carcinoma: To assess the specific contributions of CCNE1 or CDK2 for HCC progression, DEN was injected into two-week-old conditional Ccne1 or Cdk2 knockout mice with inducible Cre-recombinase under control of the Mx1-gene promoter [14].